This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Clinical trial NCT05439499 · UNKNOWN
Trial details
- NCT number
- NCT05439499
- Sponsor
- Ahon Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-02
- Primary completion
- 2024-09-20
- Enrollment
- 434
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.